A Dose Increased Once-Weekly Bortezomib-Based Combination Therapy for Multiple Myeloma

Oncotarget - United States
doi 10.18632/oncotarget.12162
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Bortezomib-Based Consolidation or Maintenance Therapy for Multiple Myeloma: A Meta-Analysis

Blood Cancer Journal
OncologyHematology
2020English

Peripheral Neuropathy Induced by Subcutaneous Bortezomib-Based Induction Therapy for Newly Diagnosed Multiple Myeloma

Haematologica
Hematology
2014English

STK405759 as a Combination Therapy With Bortezomib or Dexamethasone, in in Vitro and in Vivo Multiple Myeloma Models

Oncotarget
Oncology
2018English

Combination Therapy for Multiple Myeloma: How Far Have We Come?

Journal of Developing Drugs
2012English

Bortezomib for the Treatment of Multiple Myeloma Patients

Health Technology Assessment
MedicineHealth Policy
2009English

Treatment Responses With Once-Weekly Teriparatide Therapy for Osteoporosis

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2016English

Curcumin in Combination With Bortezomib Synergistically Induced Apoptosis in Human Multiple Myeloma U266 Cells

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2008English

Efficacy and Safety of Reduced-Intensity Induction Therapy With a Bortezomib-Based Regimen in Elderly Patients With Multiple Myeloma

Therapeutic Advances in Hematology
Hematology
2012English

Weekly Low-Dose Methotrexate Therapy for Sarcoidosis.

Internal Medicine
Internal MedicineMedicine
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy